ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 19 filers reported holding ANI PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 18,779 | $20,315,000 | 3.48% |
| Wellesley Asset Management | 58,241 | $63,483,000 | 3.40% |
| DLD Asset Management, LP | 16,000,000 | $17,360,000 | 1.71% |
| Worth Venture Partners, LLC | 1,720,000 | $1,891,000 | 1.64% |
| Perceptive Advisors | 15,000,000 | $16,238,000 | 0.31% |
| D.A. DAVIDSON & CO. | 125,000 | $13,367,000 | 0.26% |
| CAMDEN ASSET MANAGEMENT L P /CA | 2,030,000 | $2,203,000 | 0.07% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,500,000 | $1,641,000 | 0.06% |
| Jefferies Group LLC | 2,591,000 | $2,815,000 | 0.02% |
| GABELLI FUNDS LLC | 2,000,000 | $2,167,000 | 0.01% |